UNQ Holdings Limited (HK:2177)
:2177
Top Page
UNQ Holdings Limited
(2177)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$3.00
▲(4.17% Upside)
Action:ReiteratedDate:12/10/25
The overall stock score of 64 reflects a mix of strengths and challenges. The most significant factor is the strong technical momentum, although overbought signals suggest caution. Financial performance is a concern due to declining revenues and profitability issues, but positive cash flow provides some stability. The high dividend yield enhances the stock's appeal, despite valuation being fair.
Positive Factors
Diversified healthcare business model
Operating across biotech, medical devices and health services creates multiple, complementary revenue streams (product sales, licensing, partnerships). This diversification reduces concentration risk and supports resilience and strategic optionality for 2-6+ months of execution and deal-making.
Negative Factors
Declining revenue trend
Sustained revenue declines suggest weakening market adoption or competitive pressure. Falling top-line restricts reinvestment capacity, forces tougher allocation decisions for R&D and commercialization, and makes sustaining long-term growth targets more challenging without strategic inflection.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified healthcare business model
Operating across biotech, medical devices and health services creates multiple, complementary revenue streams (product sales, licensing, partnerships). This diversification reduces concentration risk and supports resilience and strategic optionality for 2-6+ months of execution and deal-making.
Read all positive factors
UNQ Holdings Limited (2177) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$403.12M
Dividend Yield15.24%
Average Volume (3M)54.97K
Price to Earnings (P/E)10.5
Beta (1Y)0.03
Revenue Growth-9.26%
EPS Growth435.33%
CountryHK
Employees217
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.07
Shares Outstanding165,894,700
10 Day Avg. Volume78,620
30 Day Avg. Volume54,966
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.30
Price to Sales (P/S)0.16
P/FCF Ratio1.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UNQ Holdings Limited Business Overview & Revenue Model
Company Description
UNQ Holdings Limited provides brand e-commerce retail and wholesale solutions in the People's Republic of China. It offers personal care products for adults, personal care products for babies, beauty products, health products, and household necess...
How the Company Makes Money
UNQ Holdings Limited generates revenue through multiple streams, primarily from the sale of its healthcare products, which include proprietary medical devices and biotechnology solutions. The company also earns income from licensing agreements and...
UNQ Holdings Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.32B | 1.35B | 1.74B | 2.38B | 3.03B | 2.80B |
| Gross Profit | 421.45M | 404.69M | 456.65M | 569.16M | 900.81M | 888.11M |
| EBITDA | 26.02M | 29.55M | 2.80M | -103.11M | 90.18M | 81.77M |
| Net Income | 24.67M | 37.89M | -18.22M | -117.92M | 30.48M | -1.09M |
Balance Sheet | ||||||
| Total Assets | 1.18B | 1.19B | 1.16B | 1.77B | 2.03B | 1.79B |
| Cash, Cash Equivalents and Short-Term Investments | 364.72M | 451.27M | 357.22M | 417.64M | 447.08M | 252.33M |
| Total Debt | 227.47M | 204.47M | 232.05M | 452.10M | 596.86M | 647.65M |
| Total Liabilities | 440.71M | 469.48M | 430.09M | 1.00B | 1.14B | 1.18B |
| Stockholders Equity | 736.84M | 719.47M | 726.28M | 762.97M | 892.60M | 618.73M |
Cash Flow | ||||||
| Free Cash Flow | -6.67M | 172.19M | 142.75M | 259.68M | -129.04M | -378.04M |
| Operating Cash Flow | -6.64M | 172.19M | 143.75M | 260.03M | -124.75M | -368.42M |
| Investing Cash Flow | 8.08M | -78.00K | -29.66M | -80.87M | 60.70M | 35.92M |
| Financing Cash Flow | -1.85M | -71.36M | -193.85M | -203.12M | 254.74M | 64.22M |
UNQ Holdings Limited Technical Analysis
Negative
2.88
Price Trends
2.61
Negative
2.74
Negative
2.73
Negative
Market Momentum
-0.05
Positive
39.95
Neutral
13.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2177, the sentiment is Negative. The current price of 2.88 is above the 20-day moving average (MA) of 2.51, above the 50-day MA of 2.61, and above the 200-day MA of 2.73, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 39.95 is Neutral, neither overbought nor oversold. The STOCH value of 13.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2177.
UNQ Holdings Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$486.05M | 5.29 | 16.67% | 8.33% | 21.99% | 11.36% | |
74 Outperform | HK$619.51M | 2.89 | 10.59% | 10.87% | 6.86% | 18.44% | |
64 Neutral | HK$403.12M | 10.47 | 3.39% | 15.24% | -9.26% | 435.33% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$615.65M | 6.41 | 4.03% | ― | -0.92% | -71.88% | |
58 Neutral | HK$368.85M | 2.21 | 11.16% | ― | 11.10% | -4.38% | |
48 Neutral | HK$562.98M | -20.98 | -10.08% | 1.72% | -3.49% | -1567.01% |
* Consumer Defensive Sector Average
HK:2177
UNQ Holdings Limited
2.43
1.25
105.93%
HK:3828
Ming Fai International Holdings
0.85
0.00
0.00%
HK:1925
Kwung's Holdings Limited
1.20
-0.12
-9.09%
HK:2023
China Ludao Technology Co. Ltd.
0.75
-0.16
-17.58%
HK:2138
EC Healthcare
0.48
-0.22
-32.14%
HK:3332
Nanjing Sinolife United Co., Ltd. Class H
0.38
-0.12
-24.00%
UNQ Holdings Limited Corporate Events
UNQ Holdings Completes 90% Acquisition of Japanese Company One Two Co., Ltd.
Jan 5, 2026
UNQ Holdings Limited has completed the acquisition of approximately 90% of the issued shares of Japan-based One Two Co., Ltd., after all conditions under the share purchase agreement were satisfied on 5 January 2026. Following completion, One Two ...
UNQ Holdings Shareholders Approve 2026 Products Procurement Framework Agreement
Dec 24, 2025
UNQ Holdings Limited announced that shareholders overwhelmingly approved, by poll, the 2026 Products Procurement Framework Agreement and its proposed annual caps at an extraordinary general meeting held in Shanghai on 24 December 2025, with 100% o...
UNQ Holdings Acquires Majority Stake in Japanese Company
Dec 15, 2025
UNQ Holdings Limited has announced a significant acquisition involving the purchase of approximately 90% of the shares of a Japanese company for JPY2,701,000,000 (around HK$135,050,000). This acquisition will result in the Japanese company becomin...
UNQ Holdings Limited Announces Extraordinary General Meeting for Strategic Approvals
Nov 26, 2025
UNQ Holdings Limited, a company incorporated in the Cayman Islands, has announced an extraordinary general meeting scheduled for December 24, 2025, in Shanghai, China. The meeting will focus on approving the 2026 Products Procurement Framework Agr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.